Russia introduces one-dose COVID vaccine, Sputnik Light. Efficacy: 80%

Russia on Thursday approved a single-dose Sputnik V coronavirus vaccine, reported AFP quoting the manufacturers .

Releasing a statement, Russian Direct Investment Fund (RDIF) said that Sputnik Light “demonstrated 79.4 percent efficacy” compared to 91.6 percent for the two-shot Sputnik V. RDIF funded the vaccine.

Also Read| New COVID-19 vaccines knocking at India’s door: All you need to know

The injection was administered as part of Russia’s mass vaccination programme between December 5, 2020 and April 15, 2021. The results were drawn from “data taken from 28 days.” 

Over 60 countries have approved the Russian vaccine.

But it has not yet been approved by the European Medicines Agency (EMA) or the United States’ Food and Drug Administration (FDA).

Some Western countries have been wary of Sputnik V — named after the Soviet-era satellite — over concerns the Kremlin would use it as a soft-power tool to advance its interests.

Moscow registered the jab in August before large-scale clinical trials, but leading medical journal The Lancet has since said it is safe and with two doses is more than 90 percent effective.

A statement said that the state-run Gamaleya research institute, which developed Sputnik V vaccine, and RDIF had launched third-phrase trials of Sputnik in several countries, including Russia, the UAE and Ghana, in February involving 7,000 people with interim results expected this year.

It said more than 20 million people globally have received their first shot of Sputnik V.